ZW171

· Zymeworks BC Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ZW171, covering 2025-10-21 to 2025-10-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ZW171 in Participants With Advanced or Metastatic Mesothelin-expressing Cancers [Phase 1]